U.S. market Closed. Opens in 11 hours 43 minutes

SONN | Sonnet BioTherapeutics Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302017-12-31
Revenue147.81K349.94K483.63KN/A40.61M41.43M
Cost of Revenue75.75K93.26K16.63M58.31K7.93M13.69M
Gross Profit72.06K256.69K-16.15M-58.31K32.68M27.74M
Operating Expenses18.94M30.02M25.57M17.41M4.71M9.74M
Selling, General & Admin7.13M8.58M8.94M7.53M2.51M4.55M
Research & Development11.81M21.44M16.63M9.88M2.20MN/A
Other Operating ExpensesN/AN/A125.50KN/A11.05M5.19M
Operating Income-18.79M-29.67M-25.09M-24.24M-4.71M-5.24M
Other Expenses / Income-40.08K-52.48K103.47K-27.34K-162.87K-2.58M
Before Tax Income-18.83M-29.72M-24.98M-24.27M-4.87M-7.81M
Income Tax Expenses40.08K52.48K22.03K6.80M162.87K644.43K
Net Income-18.83M-29.77M-25.01M-31.06M-5.03M-6.79M
Interest ExpensesN/A-40.77KN/A20.68K-2.53M-2.59M
Basic Shares Outstanding1.04M197.46K79.70K30.59K871.002.53M
Diluted Shares Outstanding1.04M197.46K79.70K30.59K871.002.53M
EBITDA-18.68M-29.62M-24.97M-10.54M-4.71M-6.46M
EBITDA Margin-12,636.10%-8,463.34%-5,163.13%0.00%-11.59%-15.59%
EBIT-18.79M-29.76M-24.98M-24.24M-7.40M-8.74M
EBIT Margin-12,714.47%-8,504.99%-5,165.97%0.00%-18.22%-21.10%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙